A review of wave energy converter technology von Drew, B, Plummer, A R, Sahinkaya, M N

Volltext

Poly(ADP-ribose)polymerase (PARP) Inhibitors: From Bench to Bedside von Plummer, R

Volltext

Numerical investigation of wave–structure interaction using OpenFOAM von Chen, L.F., Zang, J., Hillis, A.J., Morgan, G.C.J., Plummer, A.R.

Volltext

Diagnosis and Management of Adverse Local Tissue Reactions Secondary to Corrosion at the Head-Neck Junction in Patients With Metal on Polyethylene Bearings von Plummer, Darren R., MD, MBA, Berger, Richard A., MD, Paprosky, Wayne G., MD, Sporer, Scott M., MD, Jacobs, Joshua J., MD, Della Valle, Craig J., MD

Volltext

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer von Coombes, R. C., Badman, P. D., Lozano-Kuehne, J. P., Liu, X., Macpherson, I. R., Zubairi, I., Baird, R. D., Rosenfeld, N., Garcia-Corbacho, J., Cresti, N., Plummer, R., Armstrong, A., Allerton, R., Landers, D., Nicholas, H., McLellan, L., Lim, A., Mouliere, F., Pardo, O. E., Ferguson, V., Seckl, M. J.

Volltext

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study von Dummer, R., Guminksi, A., Gutzmer, R., Lear, J.T., Lewis, K.D., Chang, A.L.S., Combemale, P., Dirix, L., Kaatz, M., Kudchadkar, R., Loquai, C., Plummer, R., Schulze, H.‐J., Stratigos, A.J., Trefzer, U., Squittieri, N., Migden, M.R.

Volltext

Cutaneous immune‐related adverse events in patients with melanoma treated with checkpoint inhibitors von Gault, A., Anderson, A.E., Plummer, R., Stewart, C., Pratt, A.G., Rajan, N.

Volltext

The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus von Ninan, Ipe, Bath, Kevin G, Dagar, Karishma, Perez-Castro, Rosalia, Plummer, Mark R, Lee, Francis S, Chao, Moses V

Volltext

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study von Lear, J.T., Migden, M.R., Lewis, K.D., Chang, A.L.S., Guminski, A., Gutzmer, R., Dirix, L., Combemale, P., Stratigos, A., Plummer, R., Castro, H., Yi, T., Mone, M., Zhou, J., Trefzer, U., Kaatz, M., Loquai, C., Kudchadkar, R., Sellami, D., Dummer, R.

Volltext

Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses von Plummer, Joseph R, McGettigan, James P

Volltext

Large Sulphur Isotope Fractionations in Martian Sediments at Gale Crater von Franz, H. B., McAdam, A. C., Ming, D. W., Freissinet, C., Mahaffy, Paul, Eldridge, D. L., Fischer, W. W., Grotzinger, J. P., House, C. H., Hurowitz, J. A., McLennan, S. M., Schwenzer, S. P., Vaniman, D. T., Archer, P. D. Jr, Atreya, S. K., Conrad, P. G., Dottin, J. W. III, Eigenbrode, J. L., Farley, K. A., Glavin, D. P., Johnson, S. S., Knudson, C. A., Morris, R. V., Navarro-Gonzalez, R., Pavlov, A. A., Plummer, R., Rampe, E. B., Stern, J. C., Steele, A., Summons, R. E., Sutter, B.

Volltext

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib von Mateo, J., Moreno, V., Gupta, A., Kaye, S. B., Dean, E., Middleton, M. R., Friedlander, M., Gourley, C., Plummer, R., Rustin, G., Sessa, C., Leunen, K., Ledermann, J., Swaisland, H., Fielding, A., Bannister, W., Nicum, S., Molife, L. R.

Volltext

Cytoplasmic ATM in Neurons Modulates Synaptic Function von Li, Jiali, Han, Yu R., Plummer, Mark R., Herrup, Karl

Volltext

Study of self-diffraction from laser generated plasma gratings in the nanosecond regime von Schrauth, S. E., Colaitis, A., Luthi, R. L., Plummer, R. C. W., Hollingsworth, W. G., Carr, C. W., Norton, M. A., Wallace, R. J., Hamza, A. V., MacGowan, B. J., Shaw, M. J., Spaeth, M. L., Manes, K. R., Michel, P., Di Nicola, J.-M.

Volltext

The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma von McConnell, A.T., Ellis, R., Pathy, B., Plummer, R., Lovat, P.E., O'Boyle, G.

Volltext

A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors von Soria, J.C., Gan, H.K., Blagden, S.P., Plummer, R., Arkenau, H.T., Ranson, M., Evans, T.R.J., Zalcman, G., Bahleda, R., Hollebecque, A., Lemech, C., Dean, E., Brown, J., Gibson, D., Peddareddigari, V., Murray, S., Nebot, N., Mazumdar, J., Swartz, L., Auger, K.R., Fleming, R.A., Singh, R., Millward, M.

Volltext

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours von Plummer, R, Wilson, R H, Calvert, H, Boddy, A V, Griffin, M, Sludden, J, Tilby, M J, Eatock, M, Pearson, D G, Ottley, C J, Matsumura, Y, Kataoka, K, Nishiya, T

Volltext

Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022 von Araujo, D., Greystoke, A., Bates, S., Bayle, A., Calvo, E., Castelo-Branco, L., de Bono, J., Drilon, A., Garralda, E., Ivy, P., Kholmanskikh, O., Melero, I., Pentheroudakis, G., Petrie, J., Plummer, R., Ponce, S., Postel-Vinay, S., Siu, L., Spreafico, A., Stathis, A., Steeghs, N., Yap, C., Yap, T.A., Ratain, M., Seymour, L.

Volltext

Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer von Coombes, R. C., Badman, P. D., Lozano-Kuehne, J. P., Liu, X., Macpherson, I. R., Zubairi, I., Baird, R. D., Rosenfeld, N., Garcia-Corbacho, J., Cresti, N., Plummer, R., Armstrong, A., Allerton, R., Landers, D., Nicholas, H., McLellan, L., Lim, A., Mouliere, F., Pardo, O. E., Ferguson, V., Seckl, M. J.

Volltext

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers von Harrington, K J, Billingham, L J, Brunner, T B, Burnet, N G, Chan, C S, Hoskin, P, Mackay, R I, Maughan, T S, Macdougall, J, McKenna, W G, Nutting, C M, Oliver, A, Plummer, R, Stratford, I J, Illidge, T

Volltext